Sector

Corrections health services

Onsite point of care health screening for correctional facilities across Australia, Aotearoa New Zealand, and the Pacific. Cuts external medical escorts, closes reception screening windows faster, and supports universal opt-out blood-borne virus screening in line with the Australian and New Zealand national hepatitis C elimination strategies. No new clinical services or new entitlements. The clinical assessment that already happens, delivered onsite with less external referral and less operational risk.

Contact corrections team

Capability

Operationally efficient screening for a high cost, high risk population

External medical referrals are the largest variable cost in correctional health on both sides of the Tasman. Across the Pacific, where onsite clinical capacity is limited, external referral is often not feasible at all. Onsite point of care health screening cut escort numbers in well-resourced systems, deliver capability that does not otherwise exist in resource-constrained systems, and let custodial health teams in every setting meet existing screening and documentation obligations without expanding the service envelope.

Reception screening onsite

Intake assessment completed onsite in approximately 15 minutes. No external pathology referral, no waiting on lab turnaround. Supports universal opt-out blood-borne virus screening at reception, aligned with the Australian National Hepatitis C Strategy and the National Hepatitis C Action Plan for Aotearoa New Zealand (Mahere Mahi mo te Ate Kaka C 2020-2030). Closes the reception screening window faster and creates an auditable clinical record.

Fewer custody escorts, lower transport burden

Each external medical escort requires two custody officers, transport, and clinical-time coordination, and creates a security exposure window. Australian industry estimates place the average NSW external escort cost above $1,000 per trip. New Zealand systems carry equivalent structural cost. Pacific systems may not have feasible external referral at all, particularly where the nearest pathology lab is on another island. Onsite point of care testing addresses all three: cost lever, transport burden, capability gap.

Outbreak surveillance and population control

Same-day blood-borne virus and sexually transmissible infection results enable early isolation, treatment, and contact tracing decisions inside the facility. Population-level reporting through DAX analytics flags emerging clusters before they reach outbreak notification thresholds. One Australian facility recorded 250 new and re-infection hepatitis C notifications across 16 months; closed populations across the region carry the same concentrated transmission risk. Pacific facilities operating with limited isolation capacity benefit most from early detection. Surveillance is the foundational population-control tool.

Drug and alcohol testing on demand

The standalone EVEDA DtX device delivers a 16 parameter oral fluid screen in approximately 10 minutes. AS/NZS 4760:2019 compliant for both Australian and New Zealand workplace and custodial contexts. Supports clinical triage at reception, withdrawal management planning, and ongoing monitoring without specialist phlebotomy or external pathology referral.

Transfer, transport, and court fitness

Health status verification before transfer to another facility, court appearance, or external appointment can be completed onsite in minutes. Reduces cancelled transfers due to incomplete health documentation and the rescheduling cost that follows. Particularly relevant for inter-island transfers in the Pacific and inter-region transfers in Australia and New Zealand, where transport itself is the operational risk. Supports duty of care continuity across the custody chain.

Pre-release health summary

Mandatory pre-release health information is generated from the in-custody screening record carried by Health Passport. Supports the existing pre-release planning obligation under Australian state custodial health standards and the Aotearoa New Zealand corrections health framework. Reduces administrative burden on health staff and supports continuity to community providers without bespoke handover work. Particularly valuable where the receiving community provider is geographically distant or under-resourced.

ARTG listed (Class IIb)Medsafe NZISO 13485Randox and RCPA QAP validated

The operational picture

Meeting existing standards with fewer resources and less external referral

Correctional health procurement across Australia, Aotearoa New Zealand, and the Pacific is not a question of how much care to add. In well-resourced systems it is a question of how to meet the standards already in force with fewer external referrals, fewer custody escorts, and less operational risk. In resource-constrained Pacific systems it is a question of how to deliver the basic obligation at all without lab access. Onsite point of care health screening address both. No new clinical service category. No expanded entitlement. The clinical assessment that already happens, delivered faster and onsite.

External referrals are the cost (and the risk)

The dominant variable in the custodial health budget across the region is the rate of external medical referrals. Each external trip carries two custody officers, transport, lost facility time, and a documented security exposure. In Australia and New Zealand, reducing the referral rate is the most direct cost lever available. In Pacific settings where the nearest pathology lab may sit on another island, onsite point of care screening at reception delivers capability that otherwise does not exist. Both scenarios converge on the same answer.

Reception screening is mandatory, not optional

In Australia, the Healthcare Services Quality Framework for Victorian Prisons 2025 and the RACGP Standards for health services in Australian prisons both require structured reception assessment within a defined window. In Aotearoa New Zealand, Ara Poutama Aotearoa health services are subject to Ombudsman oversight and aligned with the national hepatitis C action plan's opt-out screening direction. Across the Pacific, WHO Western Pacific health-security guidance treats early identification as the foundation of any custodial public-health response. The obligation is fixed. The question is whether the screening is delivered onsite in 15 minutes or via an external pathway taking days. Faster screening closes the window and creates an auditable record without adding clinical scope.

Outbreak risk is operational risk

Closed populations carry concentrated transmission risk wherever they sit. One Australian correctional facility recorded 250 new and re-infection hepatitis C notifications across 16 months. Both Australia and New Zealand have national hepatitis C elimination strategies recommending universal opt-out screening at reception. Pacific facilities, often with limited isolation infrastructure, depend even more heavily on early detection. The Arthur Gorrie and West Moreton point of care rollouts in Australia and the Ministry of Health-funded mobile hepatitis C screening service in New Zealand demonstrate the operational model is established and acceptable across the region.

The device

One integrated device, 300+ screening tests

The EVEDA HubX captures data across six core health systems using five drops of blood and a urine sample. No venepuncture. No external laboratory. Results in 15 minutes. Drug and alcohol screening is delivered through the standalone EVEDA DtX device.

EVEDA HubX portable point of care screening device

Lower the cost of doing what you already do

Contact our corrections health team to model the operational saving against your facility's current external referral volume, reception screening throughput, and pre-release documentation overhead.

Contact corrections team View regulatory status